Arvee Laboratories (India) Ltd. (NSE:ARVEE)

India flag India · Delayed Price · Currency is INR
158.00
+4.84 (3.16%)
Mar 10, 2026, 2:37 PM IST
8.22%
Market Cap 1.69B
Revenue (ttm) 271.60M
Net Income (ttm) 20.75M
Shares Out 11.02M
EPS (ttm) 1.88
PE Ratio 81.48
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 71
Average Volume 649
Open 160.00
Previous Close 153.16
Day's Range 158.00 - 160.00
52-Week Range 134.65 - 290.78
Beta 0.48
RSI 42.46
Earnings Date Feb 13, 2026

About NSE:ARVEE

Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinit... [Read more]

Sector Materials
Founded 2012
Employees 70
Stock Exchange National Stock Exchange of India
Ticker Symbol ARVEE
Full Company Profile

Financial Performance

In fiscal year 2025, NSE:ARVEE's revenue was 384.87 million, an increase of 26.83% compared to the previous year's 303.45 million. Earnings were 21.47 million, an increase of 104.15%.

Financial Statements

News

There is no news available yet.